Literature DB >> 15218183

Sialidase, receptor-binding and fusion-promotion activities of Newcastle disease virus haemagglutinin-neuraminidase glycoprotein: a mutational and kinetic study.

Laura Ferreira1, Isabel Muñoz-Barroso1, Fernando Marcos1, Valery L Shnyrov1, Enrique Villar1.   

Abstract

Mutations were generated in residues at the putative catalytic site of the haemagglutinin-neuraminidase (HN) protein of Newcastle disease virus Clone 30 strain (Arg498, Glu258, Tyr262, Tyr317 and Ser418) and their effects on its three associated activities were studied. Expression of the mutant proteins at the surface of HeLa cells was similar to that of the wild-type. Sialidase, receptor-binding and fusion-promotion activities were affected to different degrees for all mutants studied. Mutant Arg498Lys lost most of its sialidase activity, although it retained most of the receptor-binding activity, suggesting that, for the former activity, besides the presence of a basic residue, the proximity to the substrate molecule is also important, as Lys is shorter than Arg. Proximity also seems to be important in substrate recognition, since Tyr262Phe retained most of its sialidase activity while Tyr262Ser lost most of it. Also, Ser418Ala displayed most of the wild-type sialidase activity. However, a kinetic and thermodynamic study of the sialidase activity of the Tyr262Ser and Ser418Ala mutants was performed and revealed that the hydroxyl group of these residues also plays an important role in catalysis, since such activity was much less effective than that of the wild-type and these mutations modified their activation energy for sialidase catalysis. The discrepancy of the modifications in sialidase and receptor-binding activities in the mutants analysed does not account for the topological coincidence of the two sites. These results also suggest that the globular head of HN protein may play a role in fusion-promotion activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218183     DOI: 10.1099/vir.0.79877-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview.

Authors:  Enrique Villar; Isabel Muñoz Barroso
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

2.  Amino Acid Mutations in Hemagglutinin-Neuraminidase Enhance the Virulence and Pathogenicity of the Genotype III Newcastle Disease Vaccine Strain After Intravenous Inoculation.

Authors:  Xiaolong Lu; Xiaowen Liu; Qingqing Song; Xiaoquan Wang; Shunlin Hu; Xiufan Liu
Journal:  Front Vet Sci       Date:  2022-05-27

3.  Mutations in the ectodomain of newcastle disease virus fusion protein confer a hemagglutinin-neuraminidase-independent phenotype.

Authors:  Juan Ayllón; Enrique Villar; Isabel Muñoz-Barroso
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

4.  Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy.

Authors:  Min Gu; Wujie Liu; Lijun Xu; Yongzhong Cao; Chunfeng Yao; Shunlin Hu; Xiufan Liu
Journal:  Virol J       Date:  2011-03-31       Impact factor: 4.099

5.  Comprehensive Analysis and Characterization of Linear Antigenic Domains on HN Protein from Genotype VII Newcastle Disease Virus Using Yeast Surface Display System.

Authors:  Tao Li; Gaoling Wang; Bingtian Shi; Peixin Liu; Wei Si; Bin Wang; Li Jiang; Lunjiang Zhou; Jinsheng Xiu; Henggui Liu
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

6.  Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus.

Authors:  Zhongyuan Jin; Qiaolin Wei; Youkun Bi; Yongshan Li; Na Huo; Sujing Mou; Wenbin Wang; Haijin Liu; Zengqi Yang; Hongjun Chen; Sa Xiao
Journal:  Virol J       Date:  2021-01-06       Impact factor: 4.099

7.  The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.

Authors:  Bo-Kyoung Jung; Yong Hee An; Jin-Ju Jang; Joo Hee Jeon; Sung Hoon Jang; Hyun Jang
Journal:  PLoS One       Date:  2022-02-08       Impact factor: 3.240

8.  α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells.

Authors:  Lorena Sánchez-Felipe; Enrique Villar; Isabel Muñoz-Barroso
Journal:  Glycoconj J       Date:  2012-08-07       Impact factor: 2.916

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.